- 著者
- 
             
             Ying-Chieh TSAI
             
             Li-Hao CHENG
             
             Yen-Wenn LIU
             
             One-Jang JENG
             
             Yuan-Kun LEE
             
          
- 出版者
- BMFH Press
- 雑誌
- Bioscience of Microbiota, Food and Health (ISSN:21863342)
- 巻号頁・発行日
- vol.40, no.1, pp.1-11, 2021 (Released:2021-01-08)
- 参考文献数
- 109
- 被引用文献数
- 
             
             
             26
             
             
          
        
        Aging is recognized as a common risk factor for many chronic diseases and functional          decline. The newly emerging field of geroscience is an interdisciplinary field that aims          to understand the molecular and cellular mechanisms of aging. Several fundamental          biological processes have been proposed as hallmarks of aging. The proposition of the          geroscience hypothesis is that targeting holistically these highly integrated hallmarks          could be an effective approach to preventing the pathogenesis of age-related diseases          jointly, thereby improving the health span of most individuals. There is a growing          awareness concerning the benefits of the prophylactic use of probiotics in maintaining          health and improving quality of life in the elderly population. In view of the rapid          progress in geroscience research, a new emphasis on geroscience-based probiotics is in          high demand, and such probiotics require extensive preclinical and clinical research to          support their functional efficacy. Here we propose a new term, “gerobiotics”, to define          those probiotic strains and their derived postbiotics and para-probiotics that are able to          beneficially attenuate the fundamental mechanisms of aging, reduce physiological aging          processes, and thereby expand the health span of the host. We provide a thorough          discussion of why the coining of a new term is warranted instead of just referring to          these probiotics as anti-aging probiotics or with other similar terms. In this review, we          highlight the needs and importance of the new field of gerobiotics, past and currently          on-going research and development in the field, biomarkers for potential targets, and          recommended steps for the development of gerobiotic products. Use of gerobiotics could be          a promising intervention strategy to improve health span and longevity of humans in the          future.